NN

Neeru Narula

Active Director Director DIN 03213756
DIN 03213756 First appointment Jul 1996 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 1996
Shareholding value •••• Premium profile

About Neeru Narula

Data last updated:

Neeru Narula is a Director at Hahnemann Pharmaceuticals Private Limited (since 1996). The company operates in Healthcare. Hahnemann Pharmaceuticals Private Limited reported revenue of ₹70.5 Lakh (FY 2024).

DIN 03213756
Primary Designation Director
Industry Healthcare
First Appointment 14 Jul 1996
Oldest Company Age 30 yrs
Largest company Hahnemann Pharmaceuticals Private Limited · ₹70.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jul 19961996₹70.5 Lakh (FY 2024)Active

Board colleagues of Neeru Narula

Directorship timeline

Open interactive timeline →
Hahnemann Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neeru Narula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeru Narula

Neeru Narula currently holds 1 directorship: Hahnemann Pharmaceuticals Private Limited (Director, since 14 Jul 1996, revenue ₹70.5 Lakh (FY 2024)).

Neeru Narula was first appointed on 14 Jul 1996 as Director at Hahnemann Pharmaceuticals Private Limited.

The current boards of Neeru Narula's companies include Karan Narula (Hahnemann Pharmaceuticals Private Limited), Pooja Narula (Hahnemann Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available